Insider Trading & Ownership - Hammond Janet MJ

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hammond Janet MJ
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-01
Sale
2024-02-02
9:24 pm
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
14,029$3.843$53,913354,162
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-31
Exercise
2024-02-02
9:24 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
46,800$0354,162
(Direct)
View
2024-01-31
Option Award
2024-02-02
9:24 pm
N/A
2034-01-30
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
225,200$0354,162
(Direct)
View
2023-01-31
Option Award
2023-02-02
6:28 pm
N/A
N/A
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
337,000$0337,000
(Direct)
View
2022-01-31
Option Award
2022-02-02
5:15 pm
N/A
2032-01-30
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
190,000$0190,000
(Direct)
View
2021-01-29
Option Award
2021-02-01
4:55 pm
N/A
2031-01-28
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
160,050$0160,050
(Direct)
View

Ownership
2020-10-29
8:45 pm
N/A
2030-08-19
Atea Pharmaceuticals Inc.AVIRHammond Janet MJ
Chief Development Officer
0$0650,000
(Direct)
View